<DOC>
	<DOCNO>NCT00088153</DOCNO>
	<brief_summary>This study determine effect anorexia nervosa bone mass hormone level adolescent . Whether administration estrogen , normal hormone present puberty , help maintain bone development girl anorexia nervosa determine .</brief_summary>
	<brief_title>Effects Anorexia Nervosa Bone Mass Adolescents</brief_title>
	<detailed_description>Adolescence critical time bone mineral accretion 60-90 % peak bone mass establish period , peak bone mass major determinant bone density osteoporosis risk adulthood . Anorexia nervosa ( AN ) third common chronic illness among adolescent girl , prevalence 0.2-1.0 % . Therefore , AN occur time patient vulnerable disruption bone mineral accretion . Osteopenia major co-morbid complication AN 50-75 % female adolescent adult woman eat disorder . Women onset disorder adolescence severe osteopenia woman onset adulthood . Little known pathogenesis osteopenia adolescent population establish therapy . Improved understanding bone mineral metabolism factor predict recovery bone mineral accretion critical development therapeutic strategy preserve maximize bone mass girl onset AN adolescence . Estrogen known critical factor development peak bone mass . Although AN associated profound estrogen deficiency , control study investigate effect estrogen administration population . This research proposal address critical unanswered question regard bone abnormality adolescent anorexia nervosa . Defining change bone formation weight recuperation hormonal variable would provide insight factor essential bone mineral accretion adolescence , well predict recovery . Determination dose-dependent estrogen effect population key target intervention time active disease , long-term goal preserve peak bone mass accretion vulnerable group patient . Data obtain woman post-menopausal osteoporosis woman AN extrapolated adolescent patient active period bone growth mineralization well remodel . Given increase prevalence AN profound consequence bone health , study provide much need data enable treatment strategy severe co-morbid disease .</detailed_description>
	<mesh_term>Anorexia Nervosa</mesh_term>
	<mesh_term>Anorexia</mesh_term>
	<mesh_term>Medroxyprogesterone Acetate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>Females Only Anorexia Nervosa Amenorrhea 1218 year Normalweight girl 1218 year past present history eat disorder Diseases affect bone metabolism ( include untreated thyroid disease , premature ovarian failure , diabetes , cancer , pituitary , renal disease bone fracture within past six month ) Use prescription medication affect bone metabolism within three month Suicidality Psychosis Substance abuse Hematocrit &lt; 30 % Potassium &lt; 3.0 mmol/L Glucose &lt; 50 mg/dl .</criteria>
	<gender>Female</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Anorexia Nervosa</keyword>
	<keyword>Amenorrhea</keyword>
	<keyword>Bone Mass</keyword>
	<keyword>Growth hormone</keyword>
</DOC>